DeutschNewstral
Article
Shropshire Star on 2024-01-09 16:42
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn deal
Related news
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn dealexpressandstar.com- MGSK to buy asthma drug developer for up to $1.4 billion in pipeline push3 min readmarketwatch.com
- FGSK PLC: GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bnft.com
- FHIV treatment breakthrough boosts GSKft.com
- AGSK cheers investors with asthma drug sales, big dividendapnewsarchive.com
GSK recalls nearly 600,000 asthma inhalers due to leaksWRAL
GSK campaigns for early treatment in the fight against Asthmavanguardngr.com
Cambridge's bluebird bio licenses delivery tech to Novartis, GSKbizjournals.com- FGSK to seek US approval for experimental antibody Covid treatmentft.com
- FGSK lines up cancer treatment with US biotech dealft.com
- FGSK sees positive signs from reduced HIV treatmentft.com
- World Asthma Day 2018: Breathe easy, live a healthy life, GSK encouragesvanguardngr.com
- GSK to hire 130 workers in Zebulon to make next-gen asthma drugsbizjournals.com
- GSK wins approval for asthma drug; will be produced in Zebulonbizjournals.com
GSK Buy Write Injects Healthy Dose Of Dividend And PremiumForbes- $5.1B deal: GSK to buy Boston-area cancer drug developerbizjournals.com
- FGSK pulls out of auction to buy $20bn Pfizer businessft.com
- FGSK leads race to buy $20bn Pfizer unitft.com
- GSK strikes deal to buy US vaccine firm Affinivaxexpressandstar.com
GSK to buy biotech Bellus Health for $2BArkansas Online